Cyclooxygenase-1 Deficiency in Bone Marrow Cells Increases Early Atherosclerosis in Apolipoprotein E– and Low-Density Lipoprotein Receptor–Null Mice

Vladimir R. Babaev(Vanderbilt University Medical Center), MacRae F. Linton(Vanderbilt University), Sergio Fazio(Alzheimer's Association), Matthew D. Breyer(Johnson & Johnson (United States)), Sudhansu K. Dey(Cincinnati Children's Hospital Medical Center), Jason D. Morrow(University of Ulster), Lei Ding(Zhejiang University), Jeff Reese(Pediatrics and Genetics)
Circulation
December 28, 2005
10.1161/circulationaha.105.591537
Cited by 38

Related Papers

Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice
|Cell|1997|1.4k
Current Perspectives on Statins
|Circulation|2000|1.2k
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
|Proceedings of the National Academy of Sciences|1992|736
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732
Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
|Nature Medicine|2001|692